Beone Medicines Ltd. Class A · SSE:688235
Ball Titus B. sold 136 Beone Medicines Ltd. Class A shares (Form 4)
Traded Jun 8, 2026 · Filed Jun 10, 2026
On Jun 8, 2026, Ball Titus B. (Principal Accounting Officer) sold 136 Beone Medicines Ltd. Class A shares at an average US$271.33 for US$36,901, leaving 0 shares. Filed Jun 10, 2026 (Form 4).
- Sold
- 136 shares
- Price
- US$271.33 average (US$271.06 to US$272.08)
- Value
- US$36,901
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | American Depositary Shares | Sale | 100 | US$271.06 | 36 | Direct |
| Jun 8, 2026 | American Depositary Shares | Sale | 36 | US$272.08 | 0 | Direct |
Source
Related
- Beone Medicines Ltd. Class A
- Ball Titus B.
- Beone Medicines Ltd. Class A shareholders
- Form 4 · Ball Titus B. · Sep 3, 2026
- Form 4 · Ball Titus B. · Jun 15, 2026
- Form 4 · Wang Xiaodong · Oct 15, 2026
- Form 4 · Lee Chan Henry · Oct 2, 2026
- Form 4 · Wang Xiaodong · Sep 30, 2026
- Form 4 · Baker Bros. Advisors LP · Sep 16, 2026
- Schedule 13D/A · Baker Bros. Advisors LP · Sep 16, 2026